CMS Open Payments · Program Year 2024
AppliedVR Inc
AppliedVR Inc reported $189,093.06 across General Payments, Research, and Ownership to 85 physicians and teaching hospitals across 85 transactions.
- $189.1K Below-median payer
- All-tracks total
- 85 Below-median volume
- Transactions
- 85 Below-median reach
- Recipients
- #1019
- of 1,925 companies
AppliedVR Inc reported $189,093.06 across all CMS Open Payments tracks (General + Research + Ownership) to 85 physicians and teaching hospitals in Program Year 2024 - ranking #1019 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $189,093.06, averaging $2.2K per recipient.
AppliedVR Inc's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
18/100
Total payments
F
12/100
Transaction volume
F
11/100
Physician reach
F
11/100
Payment type diversity
F
37/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer appliedvr-inc AppliedVR Inc
$189.1K · #1019/1,925 · 0.0% industry · PY2024
- TOT $189.1K
- RANK #1019
- SHARE 0.0%
- TXN 85
- RCP 85
- CAT 3
- GEN $189.1K
- TOP1 67.0%
- PY 2024
Volume peers
Nearest volume peer: Legend Biotech USA Inc. ($189.2K)
AppliedVR Inc sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for AppliedVR Inc
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For AppliedVR Inc that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
20 transactions worth $175.7K make "Consulting Fee" the top general-payment category in the 3-category breakdown below, 92.9% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
"Consulting Fee" leads AppliedVR Inc's 3-category general-payment breakdown at $175.7K, 92.9% of the reported total.
How AppliedVR Inc divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $175.7K | 20 | 92.9% |
| Grant | $12.2K | 2 | 6.5% |
| Food and Beverage | $1.2K | 63 | 0.7% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $187,975.08 (99.4%) of $189,093.06 in this company's General Payments records across 51 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for AppliedVR Inc
The five named recipients with the highest reported General Payments from this company
- 1
Justin Yang
$126,600.00 across 14 reported transactions
- 2
Yuri Maricich
$52,500.00 across 7 reported transactions
- 3
Abraham John Kabazie
$8,750.00 across 1 reported transactions
- 4
Melissa Bailey Jorden
$62.54 across 3 reported transactions
- 5
Sheri a Coletta
$62.54 across 3 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
AppliedVR Inc ranks #1019 of 1,925 by total payments (bottom 47% by spend) but is notably more concentrated than that alone would suggest -- #316 of 1,838 by HHI (top 17% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- Avantec Vascular Corporation : $17.9K total payments, HHI 5355
- Nico Corporation : $105.7K total payments, HHI 5350
- Gebauer Company : $15.3K total payments, HHI 5350
- Affordable Pharmaceuticals, LLC : $766.7K total payments, HHI 5325
- AstraZeneca UK Limited : $15.4M total payments, HHI 5304
- Shimadzu Precision Instruments, Inc. : $67.9K total payments, HHI 5279
- AppliedVR Inc (this company) : $189.1K total payments, HHI 5275
- Partner Therapeutics, Inc. : $378.4K total payments, HHI 5272
- Gyrus ACMI, Inc. : $304.0K total payments, HHI 5269
- Boehringer Ingelheim Espana S.A. : $1.6K total payments, HHI 5266
- BioPoly LLC : $35.8K total payments, HHI 5258
- Vascular Graft Solutions Inc : $230.03 total payments, HHI 5258
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as AppliedVR Inc's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about AppliedVR Inc.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with AppliedVR Inc.
Showing 6 of 1,924 companies with CMS-reported payment data.
VOCO America Inc.
Kirwan Surgical Products LLC
Maquet Cardiovascular L.L.C.
Kulzer, LLC
Sealonix Inc.
Put this to use
AppliedVR Inc ranks #1019 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just AppliedVR Inc. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.